145 related articles for article (PubMed ID: 19932214)
21. [Molecular markers for early diagnosis of hepatocellular carcinoma].
Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):492. PubMed ID: 15329213
[No Abstract] [Full Text] [Related]
22. Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.
Huang S; Jiang F; Wang Y; Yu Y; Ren S; Wang X; Yin P; Lou J
Tumour Biol; 2017 Jun; 39(6):1010428317705763. PubMed ID: 28621228
[TBL] [Abstract][Full Text] [Related]
23. Settling the "score" with liver cancer.
Koh C; Liang TJ
J Hepatol; 2009 Jan; 50(1):7-9. PubMed ID: 19014877
[No Abstract] [Full Text] [Related]
24. Markedly increased alpha-fetoprotein concentration in serum in alcoholic liver disease: malignant tumor or nonneoplastic changes?
Kaczynski J; Jagenburg R; Lindstedt G; Wallerstedt S
Clin Chem; 1992 May; 38(5):710-6. PubMed ID: 1374690
[No Abstract] [Full Text] [Related]
25. [Guideline compliant diagnostics of hepatocellular carcinoma].
Plentz RR; Boozari B; Malek NP
Radiologe; 2014 Jul; 54(7):660-3. PubMed ID: 24981446
[TBL] [Abstract][Full Text] [Related]
26. Differential lectin reactivities of alpha-fetoprotein in hepatocellular carcinoma: diagnostic value when serum alpha-fetoprotein levels are slightly raised.
van Staden L; Bukofzer S; Kew MC; Savage N
J Gastroenterol Hepatol; 1992; 7(3):260-5. PubMed ID: 1377039
[TBL] [Abstract][Full Text] [Related]
27. [Hepatocarcinoma: a difficult diagnosis].
Madrigal Domínguez RE; Saracíbar Serrador E; Pérez-Miranda Castillo M; Velicia Llames R; Caro-Patón Gómez A
Gastroenterol Hepatol; 2002; 25(7):481-2. PubMed ID: 12139845
[No Abstract] [Full Text] [Related]
28. Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
Li X; Wu K; Fan D
Hepatology; 2009 Jul; 50(1):325. PubMed ID: 19492428
[No Abstract] [Full Text] [Related]
29. Des-gamma-carboxyprothrombin is a favorable biomarker for the early diagnosis of alfa-fetoprotein-negative hepatitis B virus-related hepatocellular carcinoma.
Liu Z; Wu M; Lin D; Li N
J Int Med Res; 2020 Feb; 48(2):300060520902575. PubMed ID: 32054358
[TBL] [Abstract][Full Text] [Related]
30. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.
Lok AS; Sterling RK; Everhart JE; Wright EC; Hoefs JC; Di Bisceglie AM; Morgan TR; Kim HY; Lee WM; Bonkovsky HL; Dienstag JL;
Gastroenterology; 2010 Feb; 138(2):493-502. PubMed ID: 19852963
[TBL] [Abstract][Full Text] [Related]
31. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.
Yi X; Yu S; Bao Y
Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771
[TBL] [Abstract][Full Text] [Related]
32. Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.
Riener MO; Stenner F; Liewen H; Hellerbrand C; Bahra M; Kristiansen G
Hepatology; 2009 Jul; 50(1):326. PubMed ID: 19496179
[No Abstract] [Full Text] [Related]
33. Occult hepatocellular carcinoma with high fucosylated alpha-fetoprotein.
Terada R; Yamamoto K; Sakaguchi K; Kiyotoshi S; Yagi T; Sadamori H; Tsuji T
J Gastroenterol Hepatol; 2001 Nov; 16(11):1310-1. PubMed ID: 11903755
[No Abstract] [Full Text] [Related]
34. Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?
Chan SL; Chan AT; Yeo W
Future Oncol; 2009 Aug; 5(6):889-99. PubMed ID: 19663737
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma in tyrosinemia type 1 without clear increase of AFP.
van Ginkel WG; Gouw AS; van der Jagt EJ; de Jong KP; Verkade HJ; van Spronsen FJ
Pediatrics; 2015 Mar; 135(3):e749-52. PubMed ID: 25667247
[TBL] [Abstract][Full Text] [Related]
36. Alpha-fetoprotein and hepatocellular carcinoma.
Colli A; Fraquelli M; Conte D
Am J Gastroenterol; 2006 Aug; 101(8):1939; author reply 1940-1. PubMed ID: 16928257
[No Abstract] [Full Text] [Related]
37. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the albumin-gamma-glutamyltransferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis.
Pompili M; Addolorato G; Pignataro G; Rossi C; Zuppi C; Covino M; Grieco A; Gasbarrini G; Rapaccini GL
J Gastroenterol Hepatol; 2003 Mar; 18(3):288-95. PubMed ID: 12603529
[TBL] [Abstract][Full Text] [Related]
39. Serum alpha-fetoprotein and hepatocellular carcinoma size.
Piantino P; Fusaro A; Daziano E
J Nucl Med Allied Sci; 1989; 33(3 Suppl):131. PubMed ID: 2480412
[No Abstract] [Full Text] [Related]
40. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
